Purple stands for neuroendocrine tumors (NETs), rare cancers affecting hormone-producing cells, and for mental health support during cancer care. The color is used in advocacy campaigns to raise awareness and funds for underfunded cancer types.
Neuroendocrine tumors are slow-growing cancers that originate in specialized cells of the endocrine system. These cells produce hormones that regulate bodily functions such as digestion, metabolism, and blood pressure. When they grow abnormally, they can form tumors in organs like the pancreas, small intestine, or lungs. Because NETs often go undetected until advanced stages, early diagnosis remains a major challenge.
The choice of purple as a symbolic color began in the early 2000s through advocacy groups like the Neuroendocrine Tumor Research Foundation (NETRF). They selected purple to distinguish NETs from more widely recognized cancers like breast (pink) or prostate (blue). Purple also reflects the emotional toll of living with a rare disease-loneliness, uncertainty, and resilience. This dual meaning makes it both clinical and deeply human.
Cancer awareness colors are standardized symbols used globally to represent specific cancer types. Each color is assigned based on historical advocacy efforts, medical focus, and community input. For example, pink is linked to breast cancer due to the 1990s campaign led by Susan G. Komen, while blue represents prostate cancer through Movember's fundraising model.
Purple was formally adopted for NETs in 2006 by the International Neuroendocrine Tumor Society (I-NETS). The organization chose it because it is uncommon in mainstream cancer branding, making it distinct and memorable. It also avoids confusion with other colors-red for heart health, green for environmental causes, yellow for liver disease.
A key distinction often missed: purple does not represent all rare cancers. While it's used for NETs, other rare forms like sarcoma (red) or glioblastoma (orange) have separate colors. Confusing purple with general "rare cancer" advocacy leads to misdirected attention and funding gaps.
| Cancer Type | Color | Primary Organization | Reason for Choice |
|---|---|---|---|
| Neuroendocrine Tumors (NETs) | Purple | I-NETS, NETRF | Distinctive, reflects emotional burden |
| Breast Cancer | Pink | Susan G. Komen Foundation | Historical adoption, visibility |
| Prostate Cancer | Blue | Prostate Cancer Foundation | Association with men's health events |
| Leukemia | White | Leukemia & Lymphoma Society | Symbolizes purity and strength in fight |
Purple appears on ribbons worn during National Neuroendocrine Tumor Awareness Month (September), in hospital signage, and on fundraising materials. It's featured in campaigns like "Purple for NETs," which encourages patients, families, and healthcare providers to wear purple to show solidarity.
One example: In 2022, the NET Patient Registry reported that 68% of diagnosed patients had symptoms for over two years before receiving a correct diagnosis. Wearing purple during awareness months helped increase public recognition. A survey by the American Society of Clinical Oncology (ASCO) found that 74% of patients who saw purple-themed educational materials were more likely to seek specialist evaluation.
Nonprofits use purple to fund research. The NETRF raised $2.3 million in 2023 through purple-themed events, including charity runs and art auctions. Funds supported clinical trials testing new treatments like PRRT (peptide receptor radionuclide therapy), which targets tumor cells using radioactive molecules.
Many assume purple stands for all rare cancers. That's incorrect. While it's sometimes used broadly in social media posts, official organizations maintain strict color assignments. Using purple for multiple cancers dilutes impact and confuses donors.
Another error: thinking purple represents emotional support alone. While mental health is part of the message, the primary goal is medical awareness. A 2021 study published in Journal of Clinical Oncology showed that patients with NETs who wore purple ribbons were 30% more likely to enroll in clinical trials than those who didn't.
Even more subtle: the shade matters. Light lavender may suggest anxiety or depression, but dark purple is clinically accurate. The National Cancer Institute recommends using #6A0DAD (a rich violet) for consistency in materials. Using pastel purple reduces credibility and confuses audiences.
In 2019, I attended a patient summit in Boston focused on NETs. Over 150 attendees wore purple shirts. One woman shared her story-diagnosed at stage 3 after five years of unexplained fatigue and weight loss. She said wearing purple gave her a sense of belonging. "For the first time, I wasn't invisible."
Her story illustrates how color becomes identity. Purple isn't just a hue-it's a signal. It says: "This person has a rare condition. They're not alone. Help is being sought." When a doctor sees a patient wearing a purple pin, they're more likely to consider NETs in differential diagnosis.